AVITA Medical (RCEL) announced the US commercial launch of its wound care product Cohealyx.
The product was co-developed with Regenity Biosciences, AVITA said Thursday in a statement.
Cohealyx was designed to support cell movement, improve blood vessel formation and create a foundation for wound healing, AVITA said.